References
- Platt MF, Butters TD. Substrate deprivation: a new therapeutic approach for the glycosphincolipid lysosomal storage disease. Expert Reviews in Molecular Medicine 2000;1–17.
- Beutler E, Grabowski GA. Gaucher'd disease. The metabolic and molecular bases of inherited disease8th edn, CR Scriver, AL Beaudet, WS Sly, D Valle. McGraw-Hill, New York 2001; 3: 3635–68
- Cox TM, Schofield JP. Gaucher's disease: clinical features and natural history. Baillieres Clin Haem. 1997; 10: 657–89
- Charrow J, Andersson HC, Kaplan P, Kolodny EH, Mistry P, Pastores G, et al. The Gaucher Registry: demographics and disease characteristics of 1698 patients with Gaucher's disease. Arch Intern Med. 2000; 160: 2835–43
- Masek BJ, Sims KB, Bove CM, Korson MS, Short P, Norman DK. Quality of life assessment in adults with type 1 Gaucher's disease. Qual Life Res. 1999; 8: 263–8
- Platt FM, Neises GR, Reinkesmeier G, Townsend MJ, Perry VH, Proia RL, et al. Prevention of lysosomal storage in Tay-Sachs mice treated with N-butyldeoxynojirimycin. Science 1997; 276: 428–31
- Pastores GM. Gaucher's disesase. Pathological features. Bailliere. s Clinical Haematology 1997; 10: 739–49
- Pastores GM, Barnett NL, Bathan P, Kolodny EH. A neurological symptom survey of patients with type 1 Gaucher's disease. J Inherit Metab Dis. 2003; 26: 641–5
- Lake BD. Gaucher's disease, 4th edn. In: Adames J, Corsellis H, Duchen LW, eds. London: Edward Arnold Ltd:1984;522–6.
- Kaga M, Azuma C, Imamura T, Murakami T. Auditory brainstem response (ABR) in infantile Gaucher's disease. Neuropediatrics 1982; 13: 207–10
- Lacey DJ, Terplan K. Correlating auditory evoked and brainstem histological abnormalities in infantile Gaucher's disease. Neurology 1984; 34: 539–41
- Kaga K, Ono M, Yakumaru K, Owada M, Mizutani T. Brainstem pathology of infantile Gaucher's disease with only wave I and II of auditory brainstem response. J Laryng Otol. 1998; 112: 1069–73
- Campbell PE, Harris CM, Sirimanna T, Vellodi A. A model of neuronopathic Gaucher's disease. J Inherit Met Dis. 2003; 26: 629–39
- Harris CM, Taylor DSI, Vellodi A. Oculomotor abnormalities in Gaucher's disease. Neuropediatrics 2000; 30: 289–93
- Schiffmann R, Heyes MP, Aerts JM, Dambrosia JM, Patterson MC, DeGraba T, et al. Prospective study of neurological responses to treatment with macrophage targeted glucocerebrosidase in patients with type 3 Gaucher's disease. Ann Neurol. 1997; 42: 613–21
- Barmiou DE, Campbell P, Liasis A, Page J, Sirimanna T, Boyd S, et al. Audiometric abnormalities in children with Gaucher's disease type 3. Neuropediatrics 2001; 32: 136–41